Development and Validation of a UPLC-MS/MS Method for the Quantitative Determination and Pharmacokinetic Analysis of Cirsimarin in Rat Plasma.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
03
2021
accepted:
26
05
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Cirsimarin is a bioactive antilipogenic flavonoid isolated from the cotyledons of
Identifiants
pubmed: 34212043
doi: 10.1155/2021/9953664
pmc: PMC8205585
doi:
Substances chimiques
Drugs, Chinese Herbal
0
Flavones
0
Flavonoids
0
Glycosides
0
cirsimarin
13020-19-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9953664Informations de copyright
Copyright © 2021 En Zhang et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest regarding the publication of this paper.
Références
J Pharm Biomed Anal. 2020 Nov 30;191:113490
pubmed: 32858342
Nat Prod Res. 2018 Dec;32(23):2835-2839
pubmed: 28948833
Fitoterapia. 2019 Mar;133:125-129
pubmed: 30599185
J Pharm Biomed Anal. 2019 Nov 30;176:112833
pubmed: 31473492
Int J Obes (Lond). 2010 Nov;34(11):1566-75
pubmed: 20458325
Bioanalysis. 2013 Dec;5(24):3023-31
pubmed: 24320128
Bioanalysis. 2012 May;4(9):1025-37
pubmed: 22612684
Mol Genet Metab. 2018 Feb;123(2):76-84
pubmed: 29290526
Metabolism. 2013 Sep;62(9):1206-17
pubmed: 23664145
Nat Prod Res. 2020 Jul;34(13):1836-1844
pubmed: 31328559
Bioanalysis. 2018 Dec;10(24):2027-2046
pubmed: 30412686
Chem Biol Interact. 2018 Sep 25;293:38-47
pubmed: 30053449